Dexmedetomidine in current anaesthesia practice- a review

Dexmedetomidine is an alpha 2 adrenergic receptor agonist, even ten times more selective than clonidine. It is a very versatile drug in anaesthesia practice, finding place in increasing number of clinical scenarios and is no more limited to intensive care unit (ICU) sedation. It is analgesic, has an...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical and diagnostic research 2014-10, Vol.8 (10), p.GE01-GE04
Main Authors: Naaz, Shagufta, Ozair, Erum
Format: Article
Language:English
Subjects:
alpha 2 adrenergic agonist
anaesthesia
Anaesthesia Section
dexmedetomidine
intensive care unit
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dexmedetomidine is an alpha 2 adrenergic receptor agonist, even ten times more selective than clonidine. It is a very versatile drug in anaesthesia practice, finding place in increasing number of clinical scenarios and is no more limited to intensive care unit (ICU) sedation. It is analgesic, has anaesthetic sparing effect, sympatholytic property, useful in other procedural sedation and also has cardiovascular stabilizing property. It reduces delirium and preserves respiratory function which adds benefits to its uses. The aim of this review is to make awareness of its role in present anaesthesia and discuss its limitations at the same time.
ISSN:2249-782X
0973-709X
DOI:10.7860/JCDR/2014/9624.4946